GC
Grimes & Company Portfolio holdings
AUM
$3.67B
1-Year Return
12.49%
This Quarter Return
+6.02%
1 Year Return
+12.49%
3 Year Return
+42.9%
5 Year Return
+87.85%
10 Year Return
+203.44%
AUM
$2.37B
AUM Growth
+$453M
(+24%)
Cap. Flow
+$340M
Cap. Flow
% of AUM
14.34%
Top 10 Holdings %
Top 10 Hldgs %
52.25%
Holding
309
New
28
Increased
109
Reduced
122
Closed
12
Top Buys
Top Sells
| 1 |
iShares Russell 2000 ETF
IWM
|
$73.5M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
$20.2M |
| 3 |
Teradyne
TER
|
$10.7M |
| 4 |
Ciena
CIEN
|
$9.31M |
| 5 |
Health Care Select Sector SPDR Fund
XLV
|
$6.87M |
Sector Composition
| 1 | Technology | 10.08% |
| 2 | Healthcare | 7.83% |
| 3 | Financials | 5.02% |
| 4 | Industrials | 4.83% |
| 5 | Consumer Discretionary | 2.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Fortune Brands Innovations
FBIN
$7.27B
| $250K | 0.01% |
4,373
-743
| -15% | -$42.4K |
|
|
GLO
252
Clough Global Opportunities Fund
GLO
$241M
| $247K | 0.01% |
48,776
| – | – |
|
253
Kinder Morgan
KMI
$58.9B
| $243K | 0.01% |
13,431
-394
| -3% | -$7.12K |
|
|
254
Teradyne
TER
$19.1B
| $241K | 0.01% |
2,754
-121,951
| -98% | -$10.7M |
|
255
Valero Energy
VLO
$48.2B
| $240K | 0.01% |
1,894
| – | – |
|
256
iShares Russell Mid-Cap Value ETF
IWS
$14.1B
| $233K | 0.01% |
2,207
+5
| +0.2% | +$527 |
|
257
iShares Core S&P Total US Stock Market ETF
ITOT
$75.3B
| $231K | 0.01% |
2,721
-2,186
| -45% | -$185K |
|
258
Occidental Petroleum
OXY
$44.8B
| $229K | 0.01% |
3,638
+49
| +1% | +$3.09K |
|
259
Agilent Technologies
A
$36.5B
| $225K | 0.01% |
+1,504
| New | +$225K |
|
260
General Dynamics
GD
$86.7B
| $224K | 0.01% |
+901
| New | +$224K |
|
261
American Tower
AMT
$93B
| $220K | 0.01% |
1,038
-21
| -2% | -$4.45K |
|
262
Elevance Health
ELV
$70.6B
| $220K | 0.01% |
428
-63
| -13% | -$32.3K |
|
263
McKesson
MCK
$85.4B
| $217K | 0.01% |
+580
| New | +$217K |
|
264
Linde
LIN
$219B
| $214K | 0.01% |
+657
| New | +$214K |
|
265
Schwab US Large-Cap Value ETF
SCHV
$13.1B
| $212K | 0.01% |
9,612
-9,210
| -49% | -$203K |
|
266
DuPont de Nemours
DD
$32.5B
| $211K | 0.01% |
+3,068
| New | +$211K |
|
267
ADMA Biologics
ADMA
$4.05B
| $207K | 0.01% |
53,314
| – | – |
|
268
Exelon
EXC
$43.7B
| $204K | 0.01% |
+4,724
| New | +$204K |
|
269
Huntington Bancshares
HBAN
$25.6B
| $188K | 0.01% |
13,305
| – | – |
|
270
Cornerstone Strategic Value Fund
CLM
$2.33B
| $168K | 0.01% |
23,217
+1,561
| +7% | +$11.3K |
|
271
Valley National Bancorp
VLY
$5.96B
| $164K | 0.01% |
14,500
| – | – |
|
272
Golub Capital BDC
GBDC
$3.91B
| $157K | 0.01% |
+11,901
| New | +$157K |
|
273
Innoviva
INVA
$1.28B
| $148K | 0.01% |
11,134
-101
| -0.9% | -$1.34K |
|
274
Oaktree Specialty Lending
OCSL
$1.22B
| $142K | 0.01% |
+6,876
| New | +$142K |
|
|
MRNS
275
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $138K | 0.01% |
34,629
| – | – |
|